Literature DB >> 11422379

Fibrate induction of the adrenoleukodystrophy-related gene (ABCD2): promoter analysis and role of the peroxisome proliferator-activated receptor PPARalpha.

S Fourcade1, S Savary, S Albet, D Gauthé, C Gondcaille, T Pineau, J Bellenger, M Bentejac, A Holzinger, J Berger, M Bugaut.   

Abstract

X-linked adrenoleukodystrophy (X-ALD) is a neurodegenerative disease due to a defect in the ABCD1 (ALD) gene. ABCD1, and the two close homologues ABCD2 (ALDR) and ABCD3 (PMP70), are genes encoding ATP-binding cassette half-transporters of the peroxisomal membrane. As overexpression of the ABCD2 or ABCD3 gene can reverse the biochemical phenotype of X-ALD (reduced beta-oxidation of very-long-chain fatty acids), pharmacological induction of these partially redundant genes may represent a therapeutic approach to X-ALD. We previously reported that the ABCD2 and ABCD3 genes could be strongly induced by fibrates, which are hypolipidaemic drugs and peroxisome-proliferators in rodents. We provide evidence that the induction is dependent on peroxisome proliferator-activated receptor (PPARalpha) as both genes were not induced in fenofibrate-treated PPARalpha -/- knock-out mice. To further characterize the PPARalpha pathway, we cloned and analysed the promoter of the ABCD2 gene, the closest homologue of the ABCD1 gene. The proximal region (2 kb) of the rat promoter displayed a high conservation with the human and mouse cognate sequences suggesting an important role of the region in regulation of the ABCD2 gene. Classically, fibrate-induction involves interaction of PPARalpha with a response element (PPRE) characterized by a direct repeat of the AGGTCA-like motif. Putative PPRE motifs of the rat ABCD2 promoter were studied in the isolated form or in their promoter context by gel-shift assay and transfection of COS-7 cells. We failed to characterize a functional PPRE, suggesting a different mechanism for the PPARalpha-dependent regulation of the ABCD2 gene.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11422379     DOI: 10.1046/j.1432-1327.2001.02249.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  18 in total

Review 1.  Current and future pharmacological treatment strategies in X-linked adrenoleukodystrophy.

Authors:  Johannes Berger; Aurora Pujol; Patrick Aubourg; Sonja Forss-Petter
Journal:  Brain Pathol       Date:  2010-07       Impact factor: 6.508

2.  ABCD2 alters peroxisome proliferator-activated receptor α signaling in vitro, but does not impair responses to fenofibrate therapy in a mouse model of diet-induced obesity.

Authors:  Xiaoxi Liu; Jingjing Liu; Shuang Liang; Agatha Schlüter; Stephane Fourcade; Stella Aslibekyan; Aurora Pujol; Gregory A Graf
Journal:  Mol Pharmacol       Date:  2014-08-14       Impact factor: 4.436

Review 3.  The peroxisomal ABC transporter family.

Authors:  Ronald J A Wanders; Wouter F Visser; Carlo W T van Roermund; Stephan Kemp; Hans R Waterham
Journal:  Pflugers Arch       Date:  2006-10-13       Impact factor: 3.657

4.  Very-long-chain and branched-chain fatty acyl-CoAs are high affinity ligands for the peroxisome proliferator-activated receptor alpha (PPARalpha).

Authors:  Heather A Hostetler; Ann B Kier; Friedhelm Schroeder
Journal:  Biochemistry       Date:  2006-06-20       Impact factor: 3.162

5.  Peroxisome proliferator-activated receptor alpha target genes.

Authors:  Maryam Rakhshandehroo; Bianca Knoch; Michael Müller; Sander Kersten
Journal:  PPAR Res       Date:  2010-09-26       Impact factor: 4.964

6.  Silencing of Abcd1 and Abcd2 genes sensitizes astrocytes for inflammation: implication for X-adrenoleukodystrophy.

Authors:  Jaspreet Singh; Mushfiquddin Khan; Inderjit Singh
Journal:  J Lipid Res       Date:  2008-08-21       Impact factor: 5.922

7.  ABCD2 is abundant in adipose tissue and opposes the accumulation of dietary erucic acid (C22:1) in fat.

Authors:  Jingjing Liu; Nadezhda S Sabeva; Saloni Bhatnagar; Xiang-An Li; Aurora Pujol; Gregory A Graf
Journal:  J Lipid Res       Date:  2010-01       Impact factor: 5.922

Review 8.  Mammalian peroxisomal ABC transporters: from endogenous substrates to pathology and clinical significance.

Authors:  Stephan Kemp; Frederica L Theodoulou; Ronald J A Wanders
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

Review 9.  Peroxisomal ABC Transporters: An Update.

Authors:  Ali Tawbeh; Catherine Gondcaille; Doriane Trompier; Stéphane Savary
Journal:  Int J Mol Sci       Date:  2021-06-05       Impact factor: 5.923

10.  ABCD2 is a direct target of β-catenin and TCF-4: implications for X-linked adrenoleukodystrophy therapy.

Authors:  Chul-Yong Park; Han-Soo Kim; Jiho Jang; Hyunji Lee; Jae Souk Lee; Jeong-Eun Yoo; Dongjin R Lee; Dong-Wook Kim
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.